Surgery Equals Drug Treatment for Bleeding in Diabetic Retinopathy

Source: Medscape

In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients commonly require both treatments, new research shows, according to a Medscape report.

“For patients who are experiencing visual loss from bleeding due to proliferative diabetic retinopathy, these strategies are both excellent treatments and can improve and then preserve visual acuity over six months to two years,” senior author Jennifer Sun, MD, of Harvard University, Cambridge, Massachusetts, said in a press statement.

Read the full article.

Related Content